Evidence map›Paper›PMID 26889747›Full record

ArticleProtein science : a publication of the Protein Society2016

Inhibition of ice recrystallization and cryoprotective activity of wheat proteins in liver and pancreatic cells.

Mélanie Chow-Shi-Yée, Jennie G Briard, Mélanie Grondin, Diana A Averill-Bates, Robert N Ben, François Ouellet

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mélanie Chow-Shi-YéeDépartement Des Sciences Biologiques, Université Du Québec À Montréal, Montréal, Canada.
Jennie G BriardDepartment of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, Canada.
Mélanie GrondinDépartement Des Sciences Biologiques, Université Du Québec À Montréal, Montréal, Canada.
Diana A Averill-BatesDépartement Des Sciences Biologiques, Université Du Québec À Montréal, Montréal, Canada.
Robert N BenDepartment of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, Canada.
François OuelletDépartement Des Sciences Biologiques, Université Du Québec À Montréal, Montréal, Canada.
Université du Québec à Montréal · CAUniversity of Ottawa · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Efficient cryopreservation of cells at ultralow temperatures requires the use of substances that help maintain viability and metabolic functions post-thaw. We are developing new technology where plant proteins are used to substitute the commonly-used, but relatively toxic chemical dimethyl sulfoxide. Recombinant forms of four structurally diverse wheat proteins, TaIRI-2 (ice recrystallization inhibition), TaBAS1 (2-Cys peroxiredoxin), WCS120 (dehydrin), and TaENO (enolase) can efficiently cryopreserve hepatocytes and insulin-secreting INS832/13 cells. This study shows that TaIRI-2 and TaENO are internalized during the freeze-thaw process, while TaBAS1 and WCS120 remain at the extracellular level. Possible antifreeze activity of the four proteins was assessed. The "splat cooling" method for quantifying ice recrystallization inhibition activity (a property that characterizes antifreeze proteins) revealed that TaIRI-2 and TaENO are more potent than TaBAS1 and WCS120. Because of their ability to inhibit ice recrystallization, the wheat recombinant proteins TaIRI-2 and TaENO are promising candidates and could prove useful to improve cryopreservation protocols for hepatocytes and insulin-secreting cells, and possibly other cell types. TaENO does not have typical ice-binding domains, and the TargetFreeze tool did not predict an antifreeze capacity, suggesting the existence of nontypical antifreeze domains. The fact that TaBAS1 is an efficient cryoprotectant but does not show antifreeze activity indicates a different mechanism of action. The cryoprotective properties conferred by WCS120 depend on biochemical properties that remain to be determined. Overall, our results show that the proteins' efficiencies vary between cell types, and confirm that a combination of different protection mechanisms is needed to successfully cryopreserve mammalian cells.

Indexed as

AnimalsAntifreeze ProteinsCells, CulturedCell SurvivalCryopreservationCryoprotective AgentsDimethyl SulfoxideHepatocytesInsulin-Secreting CellsPlant ProteinsRatsRecombinant ProteinsTriticumAntifreeze ProteinsCryoprotective AgentsDimethyl SulfoxidePlant ProteinsRecombinant Proteinscryopreservationice recrystallization inhibitionmammalian cellplant protein

Identifiers

PMID26889747
PMCPMC4838640
OpenAlexW2283983334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.